Search results for: 'market and acquisitions deal and alliances of 2020'
- Did you mean
- market and acquisition deal and alliances of 2020
- Related search terms
- marketed stage deals and alliances of 2014
- deal+texas+and+benchmarking
- market stage deals and alliances of 2015
- market stage deal and alliances of 2016
- market stage deaf and alliance of 2017
-
Syndromic Multiplex Diagnostics: Strategies and Trends, Market Forecasts by Syndrome, Place, Product and Country with Analysis and Executive Guides 2025-2029January 2025$6,995.00Syndromic Multiplex Diagnostics Markets | Global coverage | Market size | Actionable insights| Trends | Key companies | Growth forecasts
Learn More -
Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology 2020-2025March 2025$3,995.00Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2020 to 2025
Learn More -
Central Nervous System (CNS) Collaboration and Licensing Deals 2020-2025April 2025$3,995.00Central Nervous System (CNS) Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2020 to 2025
Learn More -
Clinical Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2020-2025March 2025$4,995.00The Clinical Stage Partnering Terms and Agreements in Pharma and Biotech (2020-2025) report offers in-depth insights and exclusive access to clinical-stage partnering agreements signed by the world’s leading biopharma companies, providing a detailed analysis of deal structures, financial terms and strategic collaborations.
Learn More -
Discovery Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2020-2025March 2025$4,995.00The Discovery Stage Partnering Terms and Agreements in Pharma and Biotech (2020-2025) report offers in-depth insights and exclusive access to discovery-stage partnering agreements signed by the world’s leading biopharma companies, providing a detailed analysis of deal structures, financial terms and strategic collaborations.
Learn More -
Preclinical Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2020-2025March 2025$4,995.00The Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech (2020-2025) report offers in-depth insights and exclusive access to preclinical-stage partnering agreements signed by the world’s leading biopharma companies, providing a detailed analysis of deal structures, financial terms and strategic collaborations.
Learn More -
Big Pharma Partnering Terms and Agreements 2020-2025July 2025$5,995.00Provides a detailed understanding and analysis of how and why companies enter Big Pharma partnering deals
Learn More -
Royalty Rates in Pharmaceutical and Biotechnology Deals 2010 to 2025July 2025$3,995.00Essential Benchmark Data for Dealmakers | Global coverage | Updated to 2025 | 15+ years of royalty rates | Deal financials | Contract documents | Royalty rate trends
Learn More -
Joint Venture Deals in Pharmaceuticals and Biotechnology 2016-2025April 2025$3,995.00Track JV activity across pharma and biotech with real-world examples, financial terms, and partnering trends—includes access to contract documents where available.
Learn More -
Distribution Deals in Medical Devices 2016-2025March 2025$3,995.00Distribution Deals in Medical Devices | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2025
Learn More
